Sk
Manufacturing · Korea, Republic of · 173,714 Employees
SK Inc. focuses on operating in energy, chemicals, information and communications, biopharmaceutical, mobility, materials, logistics, and service business areas. The company was formerly known as SK Holdings Co., Ltd and changed its name to SK Inc. in March 2021. SK Inc. was founded in 1991 and is headquartered in Seoul, South Korea.Read More
Sk Org Chart
Sk Email Formats
Sk uses at least 1 email format with first.last (ex. John.Smith@sk.com) being used 100% of the time
Sk Email Formats | Percentage | |
---|---|---|
first.last | John.Smith@sk.com | 100% |
Get Verified Emails
Sk News & Media
SK Life Science CEO, Donghoon Lee, Shares His Vision for the Company and Energizes Workforce Meeting in San Diego This Week
Donghoon Lee, CEO of Korean-based SK Biopharmaceuticals and its subsidiary in the U.S., SK Life Science, Inc., praised the U.S.-based workforce for their commitment toward improving the lives of patients, and renewed the companies' focus on building a foundation for growth SAN DIEGO, Feb....SK Biopharmaceuticals to Present Future Plan for Global Investors, Partners at 'SK Bio Night'
SK Inc.'s 1st SK Bio Night on the sidelines of J.P. Morgan Healthcare Conference offers a glimpse into the future of its global business in new drug, CDMO, biotech SK Biopharmaceuticals joins SK Inc.'s Bio Investment Center, SK pharmteco, or 'SK bio family,' for potential investment,...SK life science Presents Latest Data on XCOPRI® (cenobamate tablets) CV in Adults with Partial-Onset (Focal) Seizures at the AES 2022 Annual Meeting
Post-hoc analysis from open-label Phase 3 study shows treatment with cenobamate led to a reduction of concomitant anti-seizure medications (ASMs) while maintaining ≥50% and 100% seizure reduction response rates1 Analysis of 2,131 patients taking cenobamate during Phase 2 and 3 trials show...SK life science To Present Latest XCOPRI® (cenobamate tablets) CV Data at the American Epilepsy Society 2022 Annual Meeting
A leader in epilepsy research, SK life science will share ten poster presentations on its anti-seizure medication (ASM), XCOPRI, a treatment for partial-onset (focal) seizures in adults PARAMUS, N.J., Nov. 28, 2022 /PRNewswire/ -- SK Life Science, Inc., a subsidiary of SK...
Frequently Asked Questions regarding Sk
SK Inc. focuses on operating in energy, chemicals, information and communications, biopharmaceutical, mobility, materials, logistics, and service business areas. The company was formerly known as SK Holdings Co., Ltd and changed its name to SK Inc. in March 2021. SK Inc. was founded in 1991 and is headquartered in Seoul, South Korea.... Read More